Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A IO Biotech, Inc. Filed by: Chernett Jorey

May 20, 2026 5:43 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This Amendment No. 2 constitutes an exit filing for the Reporting Person (as defined below), as the Reporting Person no longer beneficially owns any shares of the Issuer.


SCHEDULE 13G



Chernett Jorey
Signature:/s/ Jorey Chernett
Name/Title:Jorey Chernett
Date:05/20/2026

Categories

SEC Filings